Search

Aim To compare the pregnancy outcomes after day 5 blastocyst-stage embryo transfers (BET) versus day 6 BET following vitrified-warmed cycle and to evaluate whether the number of embryos transferred and the chromosomal status of embryo influence effect estimates. Methods A literature search (PubMed, Embase and MEDLINE) up to January 2019 was conducted to identify studies where women with day 6 BET were compared to women with day 5 BET. Only studies published in English language, on peer-reviewed journal were considered eligible. The following subgroup analyses were performed: (i) number of embryos transferred and (ii) chromosomal status of embryo. Results From a total of 1956 articles identified, 23 observational studies were included in the meta-analysis. We observed that day 6 BET were associated with lower implantation rate (risk ratio, RR: 1.17, 95% confidence interval, CI: 1.10-1.24), clinical pregnancy rate (RR: 1.17, 95% CI: 1.10-1.24), ongoing pregnancy rate (RR: 1.15, 95% CI: 1.07-1.24) and live birth rate (RR: 1.22, 95% CI: 1.11-1.33) than day 5 BET following vitrified-warmed cycle. The subgroup analysis found that the superiority of day 5 BET compared with day 6 BET is influenced by the number of embryos transferred and chromosomal status of embryos. Conclusion Current evidence shows that day 5 BET is superior to day 6 BET following vitrified-warmed cycle in clinical practice. Due to the overall low quality of available evidence, more larger and well-conducted studies are needed to compare the pregnancy outcomes between day 5 and day 6 BET before drawing a clear conclusion.

The mitochondrial complexes are prone to sirtuin (Sirt)3-mediated deacetylation modification, which may determine cellular response to stimuli, such as oxidative stress. In this study, we show that the cytochrome c oxidase (COX)-1, a core catalytic subunit of mitochondrial complex IV, was acetylated and deactivated both in 2,2'-azobis(2-amidinopropane) dihydrochloride-treated NIH/3T3 cells and hydrogen peroxide-treated primary neuronal cells, correlating with apoptotic cell death induction by oxidative stress. Inhibition of Sirt3 by small interfering RNA or the inhibitor nicotinamide induced accumulation of acetylation of COX-1, reduced mitochondrial membrane potential, and increased cell apoptosis. In contrast, overexpression of Sirt3 enhanced deacetylation of COX-1 and inhibited oxidative stress-induced apoptotic cell death. Significantly, rats treated with ischemia/reperfusion injury, a typical oxidative stress-related disease, presented an inhibition of Sirt3-induced hyperacetylation of COX-1 in the brain tissues. Furthermore, K13, K264, K319, and K481 were identified as the acetylation sits of COX-1 in response to oxidative stress. In conclusion, COX-1 was discovered as a new deacetylation target of Sirt3, indicating that the Sirt3/COX-1 axis is a promising therapy target of stress-related diseases.-Tu, L.-F., Cao, L.-F., Zhang, Y.-H., Guo, Y.-L., Zhou, Y.-F., Lu, W.-Q., Zhang, T.-Z., Zhang, T., Zhang, G.-X., Kurihara, H., Li, Y.-F., He, R.-R. Sirt3-dependent deacetylation of COX-1 counteracts oxidative stress-induced cell apoptosis.

New and highly stable Eu(III) and Tb(III) complexes based on two triarylborane functionalized cyclen derivative ligands L1 and L2, have been achieved. The Eu(III) and Tb(III) lanthanide compounds have been found to display highly distinct and contrasting temperature-dependent dual emission and decay lifetimes, rendering them as potential sensitive temperature probes. The emission colors of the new lanthanide complexes can be tuned by controlling the ratio of the Eu(III) and Tb(III) complexes in a binary composite and the temperature. Bright white light emission based on the new binary Eu(III) and Tb(III) complexes has been achieved. Furthermore, the triarylborane functionality of the new complexes enables their use as effective probes for anions such as fluoride ions, allowing the further tuning of the lanthanide emission.

The method offers a highly enantioselective access to novel spirocyclic dihydropyranone derivatives.

The first enantioselective aza-Morita—Baylis—Hillman reaction of acrylates with ketimines derived from isatins is developed.

The first enantioselective vinylogous aldol–cyclization cascade reaction of allyl pyrazoleamides with isatins is reported. With 1 mol% of Takemoto catalyst, optically active spirocyclic oxindole–dihydropyranones were obtained in excellent yields (93–99%) and good-to-excellent enantioselectivities (82–97% ee).

The first organocatalytic Mannich coupling of pyrazoleamides with ketimines of type (I)/(VI) is reported.

A efficient procedure using a bifunctional squaramide catalyst is presented for the domino Mannich cyclization of isatin imines and 1,3-dicarbonyl compounds (II) and (IV) to produce 3-amino-2-oxindoles in high yields and excellent stereoselectivities.

The enantioselective addition of alcohols to isatin-derived N-Boc ketimines is investigated for the first time.

An enantioselective domino reaction of 4-bromo-3-oxobutanoates with isatin-derived ketimines was developed to construct 3-amino-2-oxindoles with a quaternary stereocentre. In the presence of 1 mol-% of a bifunctional squaramide organocatalyst, the desired products were achieved in high yields (90–97 %) and with excellent enantioselectivities (92–99 % ee).